BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37274917)

  • 21. Dynamic profile and clinical implications of hematological parameters in hospitalized patients with coronavirus disease 2019.
    Ding X; Yu Y; Lu B; Huo J; Chen M; Kang Y; Lou J; Liu Z
    Clin Chem Lab Med; 2020 Jul; 58(8):1365-1371. PubMed ID: 32441666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can COVID-19 Mortality be Predicted in the Emergency Room?
    Güneysu F; Guner NG; Erdem AF; Durmus E; Durgun Y; Yurumez Y
    J Coll Physicians Surg Pak; 2020 Sep; 30(9):928-932. PubMed ID: 33036676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The predictive and prognostic role of hematologic and biochemical parameters in the emergency department among coronavirus disease 2019 patients.
    Huang CY; Tsai HW; Liu CY; Liu TH; Huang HL; Chang CC; Chen WC; Sun JT
    Chin J Physiol; 2021; 64(6):306-311. PubMed ID: 34975124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complete Blood-count-based Inflammatory Score (CBCS) of COVID-19 Patients at Tertiary Care Center.
    Kumar Gothwal S; Singh VB; Shrivastava M; Banseria R; Goyal K; Singh S; Ali H; Saad Alharbi K; Singh Y; Gupta G
    Altern Ther Health Med; 2021 Jun; 27(S1):18-24. PubMed ID: 33609349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum biomarker panel for disease severity and prognosis in patients with COVID-19.
    Li J; Tang M; Liu D; Xie Z; Wang F; Yang Y
    J Clin Lab Anal; 2023 Jan; 37(2):e24831. PubMed ID: 36604799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haematological Parameters And Outcome In Hospitalized Patients With Covid-19: A Developing Country Experience.
    Iftikhar R; Kamran SM; Mirza ZE; Naseem A; Ali Shah SA; Riaz S; Fazal I; Alamgir W; Saeed F; Saleem S; Ali RS; Chaudhry QUN
    J Ayub Med Coll Abbottabad; 2021; 33(3):416-424. PubMed ID: 34487649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematological and other Laboratory Parameter Changes in COVID-19 Patients.
    Khatib Y; Samele R; Chaudhari J; Khare M; Gupte P; Sable Y; Shah V
    J Assoc Physicians India; 2023 Apr; 71(4):11-12. PubMed ID: 37355788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study.
    Wang D; Li R; Wang J; Jiang Q; Gao C; Yang J; Ge L; Hu Q
    BMC Infect Dis; 2020 Jul; 20(1):519. PubMed ID: 32677918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between serum inflammatory parameters and the disease severity in COVID-19 patients.
    Mardani R; Namavar M; Ghorbi E; Shoja Z; Zali F; Kaghazian H; Aghasadeghi MR; Sadeghi SA; Sabeti S; Darazam IA; Ahmadi N; Mousavi-Nasab SD
    J Clin Lab Anal; 2022 Jan; 36(1):e24162. PubMed ID: 34874079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study.
    Gong J; Dong H; Xia QS; Huang ZY; Wang DK; Zhao Y; Liu WH; Tu SH; Zhang MM; Wang Q; Lu FE
    BMC Infect Dis; 2020 Dec; 20(1):963. PubMed ID: 33349241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study.
    Maamar M; Artime A; Pariente E; Fierro P; Ruiz Y; Gutiérrez S; Tobalina M; Díaz-Salazar S; Ramos C; Olmos JM; Hernández JL
    Curr Med Res Opin; 2022 Jun; 38(6):901-909. PubMed ID: 35166141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced IFN-γ levels along with changes in hematologic and immunologic parameters are key to COVID-19 severity in Bangladeshi patients.
    Islam MM; Islam S; Ahmed R; Majumder M; Sarkar B; Himu MER; Kawser M; Hossain A; Mia MJ; Parag RR; Bulbul MRH; Ahmed S; Sattar MA; Biswas R; Das M; Rahman MM; Shil RK; Parial R; Chowdhury S; Das M; Noman ASM; Hossain MM
    Exp Hematol; 2023 Feb; 118():53-64.e1. PubMed ID: 36574579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of Serum Pentraxin-3 and suPAR Levels as Acute Phase Reactants in Patients with COVID-19].
    Akbayırlı U; Kaya S; Aksoy Gökmen A
    Mikrobiyol Bul; 2022 Oct; 56(4):631-644. PubMed ID: 36458710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics and risk factors of patients with severe COVID-19 in Jiangsu province, China: a retrospective multicentre cohort study.
    Liu S; Luo H; Wang Y; Cuevas LE; Wang D; Ju S; Yang Y
    BMC Infect Dis; 2020 Aug; 20(1):584. PubMed ID: 32762665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics of Egyptian male patients with COVID-19 acute respiratory distress syndrome.
    Doghish AS; Elkhatib WF; Hassan EA; Elkhateeb AF; Mahmoud EE; Ahmed MI; Khalil MAF
    PLoS One; 2021; 16(4):e0249346. PubMed ID: 33861750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coagulation profile and correlation between D-dimer, inflammatory markers, and COVID-19 severity in an Indonesian national referral hospital.
    Sukrisman L; Sinto R
    J Int Med Res; 2021 Nov; 49(11):3000605211059939. PubMed ID: 34796762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of hematological parameters as an indicator of disease severity in Covid-19 patients: Pakistan's experience.
    Waris A; Din M; Khalid A; Abbas Lail R; Shaheen A; Khan N; Nawaz M; Baset A; Ahmad I; Ali M
    J Clin Lab Anal; 2021 Jun; 35(6):e23809. PubMed ID: 34028884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for illness severity in patients with COVID-19 pneumonia: a prospective cohort study.
    Zhang N; Zhang H; Tang Y; Zhang H; Ma A; Xu F; Sun Y; Jiang L; Shan F
    Int J Med Sci; 2021; 18(4):921-928. PubMed ID: 33456349
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of neutrophil-to-lymphocyte ratio (NLR) as a marker for COVID-19 infection in Saudi Arabia: A case-control retrospective multicenter study.
    Sayed AA; Allam AA; Sayed AI; Alraey MA; Joseph MV
    Saudi Med J; 2021 Apr; 42(4):370-376. PubMed ID: 33795491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognosis of COVID-19: Changes in laboratory parameters.
    Lagadinou M; Salomou EE; Zareifopoulos N; Marangos M; Gogos C; Velissaris D
    Infez Med; 2020 Jun; 28(suppl 1):89-95. PubMed ID: 32532944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.